Thoma Capital Management LLC Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Thoma Capital Management LLC bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,487 shares of the company's stock, valued at approximately $742,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $28,000. LGT Financial Advisors LLC boosted its position in GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after buying an additional 123 shares in the last quarter. Accredited Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $30,000. Finally, Ameriflex Group Inc. acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $31,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 2.2%

NASDAQ GEHC traded down $1.57 during mid-day trading on Friday, reaching $69.96. 7,095,456 shares of the stock were exchanged, compared to its average volume of 3,466,202. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a 50 day simple moving average of $68.96 and a 200-day simple moving average of $79.09. The stock has a market cap of $32.03 billion, a P/E ratio of 16.16, a P/E/G ratio of 3.19 and a beta of 1.21. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $4.78 billion during the quarter, compared to the consensus estimate of $4.66 billion. During the same quarter last year, the firm earned $0.90 earnings per share. GE HealthCare Technologies's quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Friday, April 25th were issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date of this dividend was Friday, April 25th. GE HealthCare Technologies's payout ratio is 2.95%.

GE HealthCare Technologies announced that its board has approved a share repurchase program on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to purchase up to 3.1% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on GEHC. Citigroup cut their target price on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research report on Wednesday, April 30th. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday. The Goldman Sachs Group dropped their price target on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Piper Sandler dropped their price target on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Finally, Evercore ISI dropped their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a research note on Thursday, May 1st. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $88.27.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.